Drug Channels

DECEMBER 12, 2022

By now, you have already read innumerable articles explaining what’s in the new Inflation Reduction Act of 2022 (IRA; P.L. I can only barely scratch the surface in this article, so feel free to share your own thoughts in the comments below or on social media.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

NOVEMBER 2, 2021

Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. In upcoming articles, I’ll examine how chain and independent pharmacies will participate in these plans.

Pharmacy 98

Pharmacy Independent Pharmacies Drugs 98

Drug Channels

JANUARY 23, 2024

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). Plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independent pharmacies participating via PSAOs as preferred pharmacies.

Pharmacy 70

Pharmacy Independent Pharmacies Marketing Drugs 70

Drug Patent Watch

OCTOBER 15, 2024

Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication doesn’t quite match up with the calendar? In this article, we’ll dive deep into this pharmaceutical conundrum… Source You’re not alone.

Pharmacy 110

Pharmacy Pharmaceuticals 110

Drug Channels

APRIL 29, 2024

on how Medicare Part D plans will react to the Inflation Reduction Act Walgreens' unexpected specialty pharmacy strength A video deconstruction of my infamous Drug Channels article on GoodRx Plus, a cartoonist illustrates my recent keynote on the battle for oncology margin.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Drugs 75

Drug Channels

AUGUST 13, 2024

Drug Channels has been tracking retail pharmacies’ economic and business challenges —and Rite Aid’s troubles—for many years. Consider this article to be an opportunity for some fact-based analysis to replace your schadenfreude. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. However, buy-and-bill appears to have rebounded substantially at hospitals. Read on for full details and the latest data.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

Drug Discovery Today

MARCH 10, 2022

Heidelberg, 10 March 2022 Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD).

Pharmacy 100

Pharmacy Drugs 100

Drug Channels

MAY 14, 2020

I received good feedback on Tuesday's video about retail pharmacy. In this clip, I highlight the growth and consolidation dynamics facing the specialty pharmacy industry. I also discuss the competitive challenges facing smaller pharmacies. I'll be back with a new article next week. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs 52

Drug Channels

DECEMBER 6, 2022

In Preferred Pharmacy Networks in 2023’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More , I highlighted how those networks have taken over the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans.

Pharmacy 98

Pharmacy Drugs Marketing 98

Perficient: Drug Development

JANUARY 23, 2024

Is there anything worse than going to a pharmacy to pick up your prescriptions? Thankfully, many pharmacies have adopted home delivery services. Here are three ways pharmacies can adopt this Adobe Commerce solution to extend and secure trust with their patients. However, this presents some challenges.

Pharmacy 52

Pharmacy Doctors Production Science 52

Drug Channels

JULY 5, 2022

ET This article describes the event and explains how to purchase a registration to participate in the event. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

OCTOBER 3, 2023

Since I published the article below in July 2023 , there have been three notable market develpoments: IQVIA has reported that as as of mid-2023, there was almost no adoption of Amgen's Amjevita, the first Humira biosimilar. This month, nine biosimilar versions of adalimumab launched in the U.S.

Biosimilars 98

Biosimilars Pharmacy Marketing Pharmaceuticals 98

Drug Channels

AUGUST 31, 2020

But you will also wonder whether this business perpetuates a broken pharmacy drug pricing model. P.S. This article updates and expands on the comments I posted to @DrugChannels on Friday evening. You will admire the GoodRx management team’s business savvy in building a company that lowers out-of-pocket costs for consumers.

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

SEPTEMBER 22, 2023

In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Unfortunately, this patient didn’t know about manufacturer affordability programs.

Pharmacy 98

Pharmacy Production Drugs 98

Drug Channels

SEPTEMBER 22, 2023

In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Unfortunately, this patient didn’t know about manufacturer affordability programs.

Pharmacy 97

Pharmacy Production Drugs 97

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

Administered weekly or monthly, long-acting injectable buprenorphine provides clients with an alternative option to methadone liquid or sublingual buprenorphine tablets, which are otherwise often provided to clients via daily supervised dosing at their local pharmacy or clinic. Increases were seen for buprenorphine.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Drug Channels

DECEMBER 15, 2020

But you will also wonder whether this business perpetuates a broken pharmacy drug pricing model. P.S. This article updates and expands on the comments I posted to @DrugChannels on Friday evening. You will admire the GoodRx management team’s business savvy in building a company that lowers out-of-pocket costs for consumers.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

OCTOBER 20, 2020

Our exclusive analysis of these data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. . In upcoming articles, I’ll examine how chain and independent pharmacies will participate in these plans and what that means for pharmacy profits.

Pharmacy 52

Pharmacy Independent Pharmacies Drugs 52

Drug Channels

DECEMBER 14, 2022

In the four months since I published the article below, the issues with alternative funding programs have hit the mainstream press. Check out last week's article from Kaiser Health News: Employers Use Patient Assistance Programs to Offset Their Own Costs. pharmacies as a backup.

Pharmacy 98

Pharmacy Compliance Drugs 98

Drug Channels

OCTOBER 24, 2023

Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as a component of Part D benefit design. In upcoming articles, I’ll delve into chain and independent pharmacies’ participation in the major 2024 preferred networks.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

SEPTEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Time for our annual update on the channels for provider-administered drugs.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

OCTOBER 27, 2021

drug spending shambles into the middle of the herd Plus, The Onion summons the only humorous article about CRISPR. Believe it or not, U.S P.S. Please join the more than 12,700 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Biosimilars 75

Biosimilars Hospitals Independent Pharmacies Pharmacy 75

Drug Channels

DECEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

MARCH 24, 2021

Amazon Care, the company's virtual primary care offering, has announced a major expansion since the article below was published. Amazon is getting more serious about pharmacy. ICYMI: Introducing Amazon Pharmacy: Prescription Medications Delivered. Click here to see the original post and comments November 2020.

Pharmacy 40

Pharmacy Drugs 40

Drug Channels

SEPTEMBER 28, 2021

on international benchmarking goes viral Amazon is finally disrupting CVS—but not how you expected Plus, the best article ever about Elizabeth Holmes’s Theranos trial. P.S. Please join the more than 12,500 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. d/b/a Drug Channels Institute.

Hospitals 81

Hospitals Biosimilars Pharmacy Drugs 81

Drug Channels

JUNE 5, 2023

Join peers this August to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to inform your 2024 distribution and patient service strategies. Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Biosimilars Compliance 74

Drug Channels

AUGUST 26, 2020

Our findings span the unexpected resilience of retail pharmacies and a troubling drop in new prescription activity. Links to sources appear at the bottom of this article. I also offer a fresh perspective on recent mail controversies and the abundance of nonsensical statistics in recent news stories.

Pharmacy 40

Pharmacy Marketing Drugs 40

Drug Channels

SEPTEMBER 11, 2024

For 2024, payers report that specialty pharmacies—via white and clear bagging—have displaced buy-and-bill for a meaningful share of commercial covered lives utilizing provider-administered oncology drugs. Below, I review the latest data on 2024 trends and compare them to the pre-pandemic figures. drug channels.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

DECEMBER 10, 2024

As you reread the article below, note that some manufacturers have already announced wholesale acquisition cost (WAC) list price declines for 2025. Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Pharmaceuticals Drugs Production 52

Drug Patent Watch

DECEMBER 10, 2024

This article will delve into the importance of scientific expertise in generic drug development, highlighting the key areas where scientific knowledge is essential. Retrieved from [link] East Street Pharmacy. Johnson, W. C., & Kern, S. Scientific Considerations for Global Drug Development. Retrieved from [link] Source

Drug Development 98

Drug Development Pharmacokinetics Compliance Drugs 98

Policy Prescription

MAY 28, 2021

The title of one article in Kaiser Health News about PSM explains a lot: “Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports.” The NeedyMeds host then asks Mr.Safdar: “Are there any pharmacies in Canada that are safe to purchase brand name drugs from…? and licensed by your state board of pharmacy.”

Pharmacy 52

Pharmacy Licensing Licensing Online Pharmacies 52

Drug Channels

JULY 29, 2020

Cool off by getting up close and personal with our refreshing selection of articles and insights. The steamy, socially distanced days of summer are here. Join the more than 9,700 followers of my curated links published on @DrugChannels on Twitter.

Pharmacy 52

Pharmacy Biosimilars Drugs Pharmaceuticals 52

The Pharma Data

DECEMBER 23, 2020

A civil complaint filed Tuesday says Walmart unlawfully distributed controlled substances to its pharmacies at the height of the crisis, the Associated Press reported. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.” AP News Article. © 2020 HealthDay.

Pharmacy 52

Pharmacy Government Drugs 52

Drug Target Review

JUNE 13, 2023

Immerse yourself in exclusive content, including articles on cutting-edge cell line development and insightful interviews with industry experts. Read on as we reveal the remarkable benefits of single-cell technologies, that are helping to uncover the mechanisms that underlie cell health and behaviour in their various states.

Engineering 52

Engineering Pharmacy Drug Development Therapies 52

Drug Channels

DECEMBER 16, 2020

I expect manufacturers to escalate their challenges to the contract pharmacy elements of the program. Meanwhile, covered entities will be battling manufacturers, state Medicaid programs, their contract pharmacy partners, and perhaps even HRSA itself. The article text is pasted below for those who don't subscribe.

Pharmacy 40

Pharmacy Hospitals Drugs 40

Agency IQ

MARCH 25, 2024

FDA addressed the expanding practice of drug compounding in 1992 by issuing a compliance policy guide that clarified that pharmacies which compounded products at certain scales, for certain purposes, or without FDA approval were clearly operating “outside the bounds of traditional pharmacy practice.”

FDA 40

FDA Pharmacy Drugs Production 40